Trial of Nivolumab With Vismodegib in Patients With Basal Cell Nevus Syndrome (BCNS)
Status: Not yet recruiting
Phase of Trial: Phase II
Latest Information Update: 09 Apr 2019
Price : $35 *
At a glance
- Drugs Nivolumab (Primary) ; Vismodegib (Primary) ; Ipilimumab
- Indications Basal cell nevus syndrome
- Focus Therapeutic Use
- 05 Apr 2019 Planned initiation date changed from 1 Feb 2019 to 1 Jun 2019.
- 03 Jan 2019 Planned initiation date changed from 1 Dec 2018 to 1 Feb 2019.
- 14 Dec 2018 New trial record